Cannabinoids and neuroinflammation: Therapeutic implications

Adams, 1940, Structure of cannabidiol, a product isolated from marihuana extract of Minnesota wild hemp, J.Amer.Chem.Soc, 42, 196, 10.1021/ja01858a058 Amatriain-Fernández, 2021, The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health, Curr. Neuropharmacol., 19, 1304, 10.2174/1570159X19666201218112748 Benito, 2003, Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque assosciated glia in Alzheimer disease brains, J. Neurosci., 23, 11136, 10.1523/JNEUROSCI.23-35-11136.2003 Berk, 2011, Pathways underlying neuroprogression in bipolar disorder: focus on oxidation,oxidative stress and neurotrophic factors, Neurosci. Biobehav. Rev., 35, 10.1016/j.neubiorev.2010.10.001 Beyer, 2010, Depression-like phenotype following chronic CB1 receptor antagonism, Neurobiol.Dis., 39, 148, 10.1016/j.nbd.2010.03.020 Boran, 2021, Association between cannabinoid 1 receptor availability and glutamate levels in controls and drug free patients with first episode psychosis: a multi-model PET and IH-MRS study, Eur. Arch. Psychiat. Clin. Neurosci, 271, 677, 10.1007/s00406-020-01191-2 Borgan, 2019, In vivo availability of cannabinoid receptor 1 levels in patients with first episode psychosis, JAMA Psychiatry, 76, 1074, 10.1001/jamapsychiatry.2019.1427 Breemen van, 2022, Cannabinoids blockcellular entry of SARS-0Cov-2 and the emerging variants, J.Nat.Prodsucts. Chandra, 2017, Canabis sativa L: botany and horticulture, 79 Chen, 2017, Brain cannabinoid receptor 2: expression, function and modulation, Acta Pharmacol Sin, 38, 312, 10.1038/aps.2016.149 Christensen, 2007, Efficacy and safety of the weight loss drug rimaban:a meta-analysis of randomized trials, Lancet, 370, 1706, 10.1016/S0140-6736(07)61721-8 Clarke, 2013 Crippa, 2018, Translational investigation of the therapeutic potential of cannabidiol (CBD): towards a new age, Front. Immunol., 9, 216, 10.3389/fimmu.2018.02009 Crivelaro do Nascimento, 2020, Ferreira-Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson’s disease, Neuropharmacology, 163, 107808, 10.1016/j.neuropharm.2019.107808 Davis, 2014, Neuroprogression and schizophrenia: pathways underpinning clinical staging and therapeutic corollaries, Aust. NZJ. Psychiat., 48, 512, 10.1177/0004867414533012 Dierker, 2018, Depression and marijuana use disorder symptoms among current marijuana users, Addict. Behav., 76, 161, 10.1016/j.addbeh.2017.08.013 Duncan, 2004, Characterization of cannabinoid modification of sensory neurotransmission in the rat isolated mesenteric bed, J. Pharmac. Exp. Therap, 311, 411, 10.1124/jpet.104.067587 Görgülü, 2020, Cannabinoid Use and Depression: comparison of Natural and Synthetic Cannabinoids, Clin Med Rev Case Rep, 7, 298 Herkenham, 1990, Cannabinoid receptor location in the brain, Proc. Natl. Acad. Sci. USA, 87, 1932, 10.1073/pnas.87.5.1932 Howlett, 2002, The cannabinoid receptors, Prostaglandins Other Lipid Mediat, 68-69, 619, 10.1016/S0090-6980(02)00060-6 Jean-Gilles, 2015, Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells, Acta Physiol, 214, 63, 10.1111/apha.12474 Ke, 2016, Activation of cannabinoid Receptor 2 ameliorates DSS-Induced colitis through inhibiting NLRP3 inflammasome in macrophages, PLoS ONE, 11, 10.1371/journal.pone.0155076 Lai, 2020, Severe acute respiratory syndrome coronavirus -2 (sars-Cov-2) and coronavirus disease 2019(covid-19): the epidemic and the challenges, Int. J. Antimicrob. Agents, 55, 105, 10.1016/j.ijantimicag.2020.105924 Leonard, 2017, Inflammation and depression: a causal or co-incidental link to pathophysiology, Acta Neuropsychiat, 23, 1 Li, 2018, A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral haemorage in rats, Brain Res, 1697, 113, 10.1016/j.brainres.2018.06.006 Lu, 2016, An introduction to the endogenous cannabinoid system, Biol. Psychiat, 79, 10.1016/j.biopsych.2015.07.028 Maes, 1995, Evidence for an immune response in major depression a review and hypothesis, Prog. Neuropsychopharm. Biol. Psychiat., 1911 Martinetti, 2017, Synthetic cannabinoids: psychopharmacology, clinical aspects. Psychotic onset, CNS Neurol. Drug Targets, 1, 567 Massi, 2006, Cannabinoids, immune system and cytokine network, Curr. Pharm. Des, 12, 3135, 10.2174/138161206777947425 McCoy, 2016, Interaction between Cannabinoid system and Toll-Like receptors controls inflammation, Mediators Inflamm., 2016, 10.1155/2016/5831315 Mihov, 2016, Positron emission tomography studies on cannabinoid receptor type 1 in schizophrenia, Biol Psychiatry, 79, e97, 10.1016/j.biopsych.2016.04.015 Minichino, 2019, Measuring disturbance of the endocannabinoid system in psychosis: a systematic review and meta-analysis, JAMA Psychiatry, 76, 914, 10.1001/jamapsychiatry.2019.0970 Mlost, 2020, Cannabidiol for pain treatment; focus on pharmacology and mechanisms of action, Int. J. Mol. Sci, 21, 8870, 10.3390/ijms21228870 Monteleone, 2010, Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression, Pharmacological Research, 61, 400, 10.1016/j.phrs.2010.01.002 Morales, 2017, An overview on medicinal chemistry of synthetic and natural derivatives of cannabinoids, Front. Pharmacol, 8, 422, 10.3389/fphar.2017.00422 Moreira, 2009, Central side effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression, Res. Comm. Endocrinol. Metab., 23, 133 Moylan, 2013, The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications, Mol.Psychiat, 18, 595, 10.1038/mp.2012.33 Myint, 2003, Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis, Med. Hypothesis, 61, 519, 10.1016/S0306-9877(03)00207-X Myint, 2014, Network beyond IDO in psychiatric disorder: revisiting the neurodegeneration hypothesis, Prog. Neuropsychopharmacol. Biol. Psychiat., 48, 304, 10.1016/j.pnpbp.2013.08.008 Nguyen, 2022, Cannabidiol inhibits SARS-Cov-2 replicationthrough inductionof the host ER stress and innate immune responses, Sci.Adv, 8, eabi6110, 10.1126/sciadv.abi6110 Nimmerjahn, 2005, Resting microglia cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 Panikashvilli, 2006, The endocannabinoid 2-AG protect blood-brain barrier integrity and neuroinflammation following mild traumatic head injury, J. Neurotrauma, 32, 257 Raj, 2021, Assessment of antiviral potencies of cannabinoids against SARS-Cov-2 using computational and in vitro approaches, Int. J. Biol. Macromolecules, 168, 474, 10.1016/j.ijbiomac.2020.12.020 Ranieri, 2016, Cannabinoids and neuroinflammation:regulation of brain immune response, Recent Pat.CNS Drug Discover, 10, 178, 10.2174/1574889810666160620103725 Reddy, 2020, Targeting the endocannabinoid system: a preventative and personalised medicine-directed approach to the management of brain pathologies, EEPMAJ, 11, 217, 10.1007/s13167-020-00203-4 Richardson, 1998, Canabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors, Pain, 75, 111, 10.1016/S0304-3959(97)00213-3 Rock, 2012, Cannabidiol,a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behavour via indirect agonism of 5HT1A somatodendritic autoreceptors in the dorsal raphe nucleus, Brit. J. Pharmacol., 165, 2620, 10.1111/j.1476-5381.2011.01621.x Romero-Sandoval, 2008, Neuroimmune interactions and pain: focus on glia modulating targets, Curr. Opin. Investig. Drugs, 9, 726 Sadanandan, 2020, Cannabinoid type 2 receptors inhibit GABAA receptor-mediated currents in cerebellar Purkinje cells of juvenile mice, PLoS One, 15, 10.1371/journal.pone.0233020 Seely, 2012, Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids, Biol. Psychiat., 39, 234 Shereen, 2020, Covid-19 infection: origin, transmission and characteristics of human coronaviruses, J.Adv.Res, 24, 91, 10.1016/j.jare.2020.03.005 Suryavanshi, 2021, Cannabinoids as key regulators of inflammasome signaling: a current perspective, Front. Immunol., 11, 10.3389/fimmu.2020.613613 Tham, 2019, Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors, Brit. J. Pharmacol, 176, 1455, 10.1111/bph.14440 Thomas, 1998, Comparative receptor binding analyses of cannabinoid agonists and antagonists, J. Pharmacol. Exp. Therap., 285, 285 Tolon, 2009, The activation of cannabinoid CB2 receptors stimulates insitu and in vitro beta-amyloid removal by human macrophages, Brain. Res., 1283, 148, 10.1016/j.brainres.2009.05.098 Varatharaj, 2017, The blood-brain barrier in systemic inflammation, Brain Behav. Immun., 60, 1, 10.1016/j.bbi.2016.03.010 Wake, 2013, Microglia: actively surveying and shaping neuronal circuit structures and function, Trends Neurosci, 36, 209, 10.1016/j.tins.2012.11.007 Wang, 2022, New AKT-dependent mechanisms of anti-covid-19; action of high CBD Cannabis Sativa extracts, Cell Death Disc, 8, 110, 10.1038/s41420-022-00876-y Wotherspoon, 2005, Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons, Neurosci, 135, 235, 10.1016/j.neuroscience.2005.06.009 Zador, 2021, Pro-inflammatory cytokines: potential links between the endocnnabinoid system and the kynurenine pathway in depression, Int. J. Mol. Sci, 22, 5903, 10.3390/ijms22115903 Zhang H.Y., Shen H., Gao M., Ma Z., Hempel B.J., Bi G.H., Gardner E.L., Wu J., Xi Z.X. Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice. Neuropharmacology. 2021 May 15;189:108538. doi:10.1016/j.neuropharm.2021. Zou, 2018, Cannabinoid receptors and the endocannabinoid system, Int. J. Mol. Sci, 19, 123, 10.3390/ijms19030833